Fig. 1From: Experimental analysis of bladder cancer-associated mutations in EP300 identifies EP300-R1627W as a driver mutationHigh-throughput sequencing of 97 cases with TCC. A High-throughput sequencing of bladder cancer reveals 13 non-synonymous gene lesions in EP300. B Sequencing traces of representative mutations and corresponding wild-type EP300 constructs. Arrows point to the position of the nucleotide change. Amino acid changes are shown at the topBack to article page